GPNMB confers risk for Parkinson’s disease through interaction with α-synuclein | Science

GPNMB confers risk for Parkinson’s disease through interaction with α-synuclein | Science

Computational, cell biological, and human tissue-based studies establish GPNMB as a risk gene and therapeutic target for Parkinson’s disease…
Read More